July 10, 2008
Peg-Interferon Slows Melanoma Recurrence

ROTTERDAM, July 10 -- Adjuvant treatment with pegylated interferon alfa-2b has a significant long-lasting benefit for recurrence-free survival in resected stage III melanoma, researchers here said.   <READ MORE>

June 18, 2008
Metastatic Melanoma Succumbs to Investigational Immunotherapy

SEATTLE, June 18 -- An investigational T-cell therapy obliterated all signs of disease in a man with metastatic melanoma, researchers here said.  <READ MORE>

Apr 21, 2008
AACR: IL-12 Level May Predict Melanoma Prognosis

SAN DIEGO, April 21 -- An elevated level of interleukin-12 was associated with a significantly increased mortality risk in patients with Stage III melanoma with regional metastasis, according to data from a large cohort study. <READ MORE>

Apr 21, 2008
Melanoma More Likely in the Big Moles

NEW YORK, April 21 -- Moles with a diameter of six millimeters or less were significantly less likely to be melanoma, a computer-based study showed. <READ MORE>

Apr 18, 2008
AACR: Molecule Promising Against Advanced Basal Cell Carcinoma

SAN DIEGO, April 15 -- Eight of nine patients with metastatic basal cell carcinoma had durable clinical benefit with minimal toxicity when treated with an investigational compound that inhibits signaling in the Hedgehog pathway. <READ MORE>

Jan 21, 2008
'Ugly Duckling' Moles May Be Melanomas

NEW YORK, Jan. 21 -- An irregularly pigmented mole that looks different from other irregularly pigmented moles in the same person -- an "ugly duckling" -- is likely to be a malignant melanoma, according to a preliminary study.  <READ MORE>

Jan 17, 2008
Virus May Cause Aggressive Merkel Cell Skin Cancer

PITTSBURGH, Jan. 17 - The rare and often-deadly Merkel cell carcinoma may be induced by a polyomavirus, researchers here reported.  <READ MORE>

Oct 26, 2007
AACR-NCI-EORTC: Artificial Antibody May Help T Cells Fight Melanoma

SAN FRANCISCO, Oct. 26 -- Immunity against melanoma may turn more effective through an engineered antibody that binds cancer cells to killer T cells, said researchers here.  <READ MORE>